BindingDB logo
myBDB logout

PubMed code 2918498

Compile data set for download or QSAR
Found 18 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50024330
PNG
(3-(3-Benzyl-ureido)-3-{2-[2-tert-butoxycarbonylami...)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Show InChI InChI=1S/C35H46N6O8/c1-20(2)15-26(31(45)40-28(18-29(42)43)33(47)38-25(30(36)44)16-21-11-7-6-8-12-21)39-32(46)27(41-34(48)49-35(3,4)5)17-22-19-37-24-14-10-9-13-23(22)24/h6-14,19-20,25-28,37H,15-18H2,1-5H3,(H2,36,44)(H,38,47)(H,39,46)(H,40,45)(H,41,48)(H,42,43)/t25-,26-,27-,28-/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 500n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020575
PNG
(3-{2-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@H](CC(O)=O)CC(=O)NCCc1ccccc1 |r|
Show InChI InChI=1S/C35H47N5O7/c1-22(2)17-28(32(44)38-25(20-31(42)43)19-30(41)36-16-15-23-11-7-6-8-12-23)39-33(45)29(40-34(46)47-35(3,4)5)18-24-21-37-27-14-10-9-13-26(24)27/h6-14,21-22,25,28-29,37H,15-20H2,1-5H3,(H,36,41)(H,38,44)(H,39,45)(H,40,46)(H,42,43)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 750n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020560
PNG
(4-Benzylcarbamoyl-3-{2-[2-tert-butoxycarbonylamino...)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@H](CC(O)=O)CC(=O)NCc1ccccc1 |r|
Show InChI InChI=1S/C34H45N5O7/c1-21(2)15-27(31(43)37-24(18-30(41)42)17-29(40)36-19-22-11-7-6-8-12-22)38-32(44)28(39-33(45)46-34(3,4)5)16-23-20-35-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-28,35H,15-19H2,1-5H3,(H,36,40)(H,37,43)(H,38,44)(H,39,45)(H,41,42)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 1.00E+3n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020564
PNG
(3-{2-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@H](CC(O)=O)CC(=O)N[C@@H](Cc1ccccc1)C(N)=O |r|
Show InChI InChI=1S/C36H48N6O8/c1-21(2)15-28(33(47)39-24(19-31(44)45)18-30(43)40-27(32(37)46)16-22-11-7-6-8-12-22)41-34(48)29(42-35(49)50-36(3,4)5)17-23-20-38-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-29,38H,15-19H2,1-5H3,(H2,37,46)(H,39,47)(H,40,43)(H,41,48)(H,42,49)(H,44,45)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 1.50E+3n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020569
PNG
(3-{2-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@H](CC(O)=O)CC(=O)N[C@H](Cc1ccccc1)C(N)=O
Show InChI InChI=1S/C36H48N6O8/c1-21(2)15-28(33(47)39-24(19-31(44)45)18-30(43)40-27(32(37)46)16-22-11-7-6-8-12-22)41-34(48)29(42-35(49)50-36(3,4)5)17-23-20-38-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-29,38H,15-19H2,1-5H3,(H2,37,46)(H,39,47)(H,40,43)(H,41,48)(H,42,49)(H,44,45)/t24?,27-,28?,29?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 2.00E+3n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020561
PNG
(3-{3-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)CC(CC(=O)N[C@H](CC(O)=O)C(=O)NCCc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
Show InChI InChI=1S/C35H47N5O7/c1-22(2)17-25(19-30(41)39-29(20-31(42)43)32(44)36-16-15-23-11-7-6-8-12-23)38-33(45)28(40-34(46)47-35(3,4)5)18-24-21-37-27-14-10-9-13-26(24)27/h6-14,21-22,25,28-29,37H,15-20H2,1-5H3,(H,36,44)(H,38,45)(H,39,41)(H,40,46)(H,42,43)/t25?,28?,29-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 2.00E+3n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020573
PNG
(3-{3-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)CC(CC(=O)NC(CC(O)=O)C(=O)NCCc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
Show InChI InChI=1S/C35H47N5O7/c1-22(2)17-25(19-30(41)39-29(20-31(42)43)32(44)36-16-15-23-11-7-6-8-12-23)38-33(45)28(40-34(46)47-35(3,4)5)18-24-21-37-27-14-10-9-13-26(24)27/h6-14,21-22,25,28-29,37H,15-20H2,1-5H3,(H,36,44)(H,38,45)(H,39,41)(H,40,46)(H,42,43)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 5.00E+3n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020574
PNG
(CHEMBL356844 | N-Benzyl-3-{3-[2-tert-butoxycarbony...)
Show SMILES CC(C)CC(CC(=O)NC(CC(O)=O)C(=O)NCc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
Show InChI InChI=1S/C34H45N5O7/c1-21(2)15-24(17-29(40)38-28(18-30(41)42)31(43)36-19-22-11-7-6-8-12-22)37-32(44)27(39-33(45)46-34(3,4)5)16-23-20-35-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-28,35H,15-19H2,1-5H3,(H,36,43)(H,37,44)(H,38,40)(H,39,45)(H,41,42)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 5.00E+3n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
In vitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020567
PNG
(CHEMBL355927 | N-Benzyl-3-{3-[2-tert-butoxycarbony...)
Show SMILES CC(C)CC(CC(=O)N[C@H](CC(O)=O)C(=O)NCc1ccccc1)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
Show InChI InChI=1S/C34H45N5O7/c1-21(2)15-24(17-29(40)38-28(18-30(41)42)31(43)36-19-22-11-7-6-8-12-22)37-32(44)27(39-33(45)46-34(3,4)5)16-23-20-35-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-28,35H,15-19H2,1-5H3,(H,36,43)(H,37,44)(H,38,40)(H,39,45)(H,41,42)/t24?,27?,28-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a>1.00E+4n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020572
PNG
(3-{3-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)C[C@@H](CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C |r|
Show InChI InChI=1S/C36H48N6O8/c1-21(2)15-24(18-30(43)40-29(19-31(44)45)34(48)41-27(32(37)46)16-22-11-7-6-8-12-22)39-33(47)28(42-35(49)50-36(3,4)5)17-23-20-38-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-29,38H,15-19H2,1-5H3,(H2,37,46)(H,39,47)(H,40,43)(H,41,48)(H,42,49)(H,44,45)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 1.00E+4n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020566
PNG
(3-{3-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)C[C@@H](CC(=O)NC(CC(O)=O)C(=O)NCCc1ccccc1)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
Show InChI InChI=1S/C35H47N5O7/c1-22(2)17-25(19-30(41)39-29(20-31(42)43)32(44)36-16-15-23-11-7-6-8-12-23)38-33(45)28(40-34(46)47-35(3,4)5)18-24-21-37-27-14-10-9-13-26(24)27/h6-14,21-22,25,28-29,37H,15-20H2,1-5H3,(H,36,44)(H,38,45)(H,39,41)(H,40,46)(H,42,43)/t25-,28+,29?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 1.00E+4n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020571
PNG
(4-Benzylcarbamoyl-3-{2-[2-tert-butoxycarbonylamino...)
Show SMILES CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@H](CC(O)=O)CC(=O)NCc1ccccc1
Show InChI InChI=1S/C34H45N5O7/c1-21(2)15-27(31(43)37-24(18-30(41)42)17-29(40)36-19-22-11-7-6-8-12-22)38-32(44)28(39-33(45)46-34(3,4)5)16-23-20-35-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-28,35H,15-19H2,1-5H3,(H,36,40)(H,37,43)(H,38,44)(H,39,45)(H,41,42)/t24-,27-,28+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 1.50E+4n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020563
PNG
(CHEMBL151619 | N-Benzyl-3-{3-[2-tert-butoxycarbony...)
Show SMILES CC(C)C[C@@H](CC(=O)NC(CC(O)=O)C(=O)NCc1ccccc1)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
Show InChI InChI=1S/C34H45N5O7/c1-21(2)15-24(17-29(40)38-28(18-30(41)42)31(43)36-19-22-11-7-6-8-12-22)37-32(44)27(39-33(45)46-34(3,4)5)16-23-20-35-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-28,35H,15-19H2,1-5H3,(H,36,43)(H,37,44)(H,38,40)(H,39,45)(H,41,42)/t24-,27+,28?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 2.00E+4n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020562
PNG
(3-{2-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@H](CC(O)=O)CC(=O)NCCc1ccccc1
Show InChI InChI=1S/C35H47N5O7/c1-22(2)17-28(32(44)38-25(20-31(42)43)19-30(41)36-16-15-23-11-7-6-8-12-23)39-33(45)29(40-34(46)47-35(3,4)5)18-24-21-37-27-14-10-9-13-26(24)27/h6-14,21-22,25,28-29,37H,15-20H2,1-5H3,(H,36,41)(H,38,44)(H,39,45)(H,40,46)(H,42,43)/t25-,28-,29+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 2.50E+4n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled gCholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020576
PNG
(3-{2-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@H](CC(O)=O)CC(=O)NC(Cc1ccccc1)C(N)=O
Show InChI InChI=1S/C36H48N6O8/c1-21(2)15-28(33(47)39-24(19-31(44)45)18-30(43)40-27(32(37)46)16-22-11-7-6-8-12-22)41-34(48)29(42-35(49)50-36(3,4)5)17-23-20-38-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-29,38H,15-19H2,1-5H3,(H2,37,46)(H,39,47)(H,40,43)(H,41,48)(H,42,49)(H,44,45)/t24-,27?,28-,29+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 3.00E+4n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020577
PNG
(3-{3-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)CC(CC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(N)=O)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
Show InChI InChI=1S/C36H48N6O8/c1-21(2)15-24(18-30(43)40-29(19-31(44)45)34(48)41-27(32(37)46)16-22-11-7-6-8-12-22)39-33(47)28(42-35(49)50-36(3,4)5)17-23-20-38-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-29,38H,15-19H2,1-5H3,(H2,37,46)(H,39,47)(H,40,43)(H,41,48)(H,42,49)(H,44,45)/t24?,27-,28?,29-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 5.00E+4n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020570
PNG
(3-{2-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(N)=O)Cc1ccccc1 |r|
Show InChI InChI=1S/C36H48N6O8/c1-21(2)15-27(33(47)41-29(19-31(44)45)32(46)39-24(18-30(37)43)16-22-11-7-6-8-12-22)40-34(48)28(42-35(49)50-36(3,4)5)17-23-20-38-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-29,38H,15-19H2,1-5H3,(H2,37,43)(H,39,46)(H,40,48)(H,41,47)(H,42,49)(H,44,45)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 5.00E+4n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
Gastrin/cholecystokinin type B receptor


(Homo sapiens (Human))
BDBM50020568
PNG
(3-{3-[2-tert-Butoxycarbonylamino-3-(1H-indol-3-yl)...)
Show SMILES CC(C)C[C@H](CC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
Show InChI InChI=1S/C36H48N6O8/c1-21(2)15-24(18-30(43)40-29(19-31(44)45)34(48)41-27(32(37)46)16-22-11-7-6-8-12-22)39-33(47)28(42-35(49)50-36(3,4)5)17-23-20-38-26-14-10-9-13-25(23)26/h6-14,20-21,24,27-29,38H,15-19H2,1-5H3,(H2,37,46)(H,39,47)(H,40,43)(H,41,48)(H,42,49)(H,44,45)/t24-,27?,28+,29?/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

PubMed
n/an/a 1.00E+5n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Invitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit


J Med Chem 32: 522-8 (1989)


BindingDB Entry DOI: 10.7270/Q2MW2G4H
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%